Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-24 @ 7:10 PM
NCT ID:
NCT00383903
Eligibility Criteria:
Inclusion Criteria:
* Healthy infants born after a normal gestation period (\>=36 weeks), between 5 and 10 weeks of age at Dose 1 with confirmed negative HIV status of the subject's mother.
* Written informed consent was obtained from the parent/guardian of the subject before study entry.
Exclusion Criteria:
* History of allergic disease/polio disease,
* Confirmed or suspected immunosuppressive or immunodeficient condition,
* Clinically significant history of chronic gastrointestinal disease or other serious medical condition as determined by the investigator,
* Received treatment prohibited by the protocol.
* Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Weeks
Maximum Age:
10 Weeks
Study:
NCT00383903
Study Brief:
Protocol Section:
NCT00383903